Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Base de datos
País/Región como asunto
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Vaccine ; 41(19): 3137-3140, 2023 05 05.
Artículo en Inglés | MEDLINE | ID: mdl-37061369

RESUMEN

A cluster-randomized trial of Vi-TT was conducted in Dhaka, Bangladesh, using JE vaccine as the control. A subset of 1,500 children were randomly selected on 2:1 basis (Vi-TT vs JE) to assess immune response. Blood was collected before vaccination, and on days 28, 545 and 730 post-vaccination and plasma anti-Vi-IgG response was measured. A robust, persistent antibody response was induced after single dose of Vi-TT, even after 2 years of vaccination. While there is no accepted serological antibody threshold of protection, analyzing the antibodies of children who received Vi-TT provides evidence that may later be useful in predicting population protection.


Asunto(s)
Fiebre Tifoidea , Vacunas Tifoides-Paratifoides , Humanos , Niño , Fiebre Tifoidea/prevención & control , Toxoide Tetánico , Salmonella typhi , Vacunas Conjugadas , Bangladesh , Inmunoglobulina G , Anticuerpos Antibacterianos , Vacunación , Formación de Anticuerpos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA